SBIA
NVO

Sheaff Brock Investment Advisors’s Novo Nordisk NVO Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,027
Closed -$346K – 472
2024
Q4 		$346K Buy
4,027
+557
+16% +$60.2K 0.03% 308
2024
Q3 		$413K Buy
3,470
+150
+5% +$20K 0.04% 283
2024
Q2 		$474K Sell
3,320
-1,367
-29% -$181K 0.04% 256
2024
Q1 		$602K Buy
4,687
+20
+0.4% +$2.38K 0.04% 263
2023
Q4 		$483K Buy
+4,667
New +$462K 0.04% 276

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Sheaff Brock Investment Advisors's NVO Position: Q1 2025 in Review

Sheaff Brock Investment Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 4,027 shares — an estimated $346K sold.

Sheaff Brock Investment Advisors first reported a position in NVO in Q4 2023 and held it in 5 quarters. The position peaked at $602K in Q1 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Sheaff Brock Investment Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 4,027 Novo Nordisk shares in Q1 2025, an estimated $346K.
  • Sheaff Brock Investment Advisors first reported a position in Novo Nordisk in Q4 2023 and held it in 5 quarters.
  • Sheaff Brock Investment Advisors's Novo Nordisk position peaked at $602K in Q1 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.